A detailed history of Fmr LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 204,004 shares of HALO stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,004
Previous 49,928 308.6%
Holding current value
$12.1 Million
Previous $2.03 Million 425.9%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$37.81 - $52.4 $5.83 Million - $8.07 Million
154,076 Added 308.6%
204,004 $10.7 Million
Q1 2024

May 13, 2024

SELL
$33.68 - $41.95 $2.74 Million - $3.41 Million
-81,346 Reduced 61.97%
49,928 $2.03 Million
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $148,473 - $187,597
4,456 Added 3.51%
131,274 $4.85 Million
Q3 2023

Nov 13, 2023

SELL
$36.46 - $44.03 $103,473 - $124,957
-2,838 Reduced 2.19%
126,818 $4.84 Million
Q2 2023

Aug 11, 2023

SELL
$30.28 - $38.74 $15.4 Million - $19.7 Million
-508,585 Reduced 79.69%
129,656 $4.68 Million
Q1 2023

May 11, 2023

SELL
$32.86 - $55.7 $10.5 Million - $17.8 Million
-318,978 Reduced 33.32%
638,241 $24.4 Million
Q4 2022

Feb 13, 2023

SELL
$40.06 - $59.44 $1.78 Million - $2.64 Million
-44,395 Reduced 4.43%
957,219 $54.5 Million
Q3 2022

Nov 10, 2022

SELL
$38.53 - $51.78 $2.88 Million - $3.87 Million
-74,732 Reduced 6.94%
1,001,614 $39.6 Million
Q2 2022

Aug 12, 2022

BUY
$37.35 - $48.3 $6.55 Million - $8.46 Million
175,243 Added 19.45%
1,076,346 $47.4 Million
Q1 2022

May 13, 2022

BUY
$31.97 - $41.06 $6.97 Million - $8.95 Million
218,064 Added 31.93%
901,103 $35.9 Million
Q4 2021

Feb 14, 2022

SELL
$31.82 - $40.75 $7.41 Million - $9.49 Million
-232,965 Reduced 25.43%
683,039 $27.5 Million
Q3 2021

Nov 15, 2021

SELL
$38.47 - $46.42 $34.3 Million - $41.3 Million
-890,519 Reduced 49.29%
916,004 $37.3 Million
Q2 2021

Aug 13, 2021

BUY
$38.84 - $51.31 $70.2 Million - $92.7 Million
1,806,523 New
1,806,523 $82 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $8.29B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.